In prostate cancer patients, low serum testosterone has been found to be associated with androgen receptor expression (Schatzl et al., 2002; Husain et al., 2016; Feng and He, 2019; Hashmi et al., 2019). The gene discussed is AR; the disease is prostate cancer.